Angiographic Control Vs. Ischemia-driven Management of Patients Treated with PCI on Left Main with Drug-eluting Stents

NCT04144881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 606

Last updated 2024-11-04

No results posted yet for this study

Summary

The present study aims to compare a planned angiographic control (PAC) follow-up strategy vs. conservative management for patients treated with drug-eluting stents on unprotected left main artery in a prospective, randomized setting. PAC will be performed by coronary computed tomography (CCT), to avoid the limitations of the invasive coronary angiography which is usually employed to perform PAC. The superiority of a PAC-based approach will be tested on a hard clinical end-point such as the incidence of major adverse cardiovascular events. The investigators will also assess the performance of CCT as a tool to perform PAC.

Conditions

Interventions

DIAGNOSTIC_TEST

coronary computed tomography

patients randomized in this arm will perform computed coronary tomography 6 months after the index percutaneous revascularization on unprotected left main artery

Sponsors & Collaborators

  • Università degli Studi di Ferrara

    collaborator OTHER
  • Ospedale San Luigi Gonzaga, Orbassano

    collaborator UNKNOWN
  • Ospedale Santa Croce-Carle Cuneo

    collaborator OTHER
  • Azienda USL Reggio Emilia - IRCCS

    collaborator OTHER_GOV
  • AUSL Romagna Rimini

    collaborator OTHER
  • University of Ferrara Department of Life Sciences and Biotechnology

    collaborator UNKNOWN
  • A.O.U. Città della Salute e della Scienza

    lead OTHER

Principal Investigators

  • Fabrizio D'Ascenzo, MD · A.O.U. Città della Salute e della Scienza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2024-09-03
Completion
2024-09-03

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04144881 on ClinicalTrials.gov